Vero Biotech

Vero Biotech is a biopharmaceutical company dedicated to the design, development, and commercialization of next-generation products to meet the unmet medical needs of patients with various pulmonary and heart conditions. We are currently developing inhaled nitric oxide (NO) products for use in hospital settings and for long-term applications outside of the hospital environment. These products are based on our GeNOsyl™ drug delivery technology, consisting of a disposable drug cartridge and a portable console or wearable controller. At Vero Biotech, their mission is to improve patients' lives by developing innovative technologies for delivering inhaled NO in emergency hospitals and other areas where nitric oxide therapy is needed. They focus on innovative science, development, and commercialization, striving to exceed customer expectations in terms of safety, efficacy, and value.